% alzhub.org library filter % Source: https://alzhub.org/research?category=treatments&atag=machine % 24 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{salloway2022-34807243, author = {Salloway, S. and Chalkias, S. and Barkhof, F. and Burkett, P. and Barakos, J. and Purcell, D. and Suhy, J. and Forrestal, F. and others}, title = {{Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2021.4161}, pmid = {34807243}, url = {https://doi.org/10.1001/jamaneurol.2021.4161} } @article{grill2020-32777010, author = {Grill, J. D. and Raman, R. and Ernstrom, K. and Sultzer, D. L. and Burns, J. M. and Donohue, M. C. and Johnson, K. A. and Aisen, P. S. and others}, title = {{Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment}}, journal = {JAMA neurology}, year = {2020}, doi = {10.1001/jamaneurol.2020.2734}, pmid = {32777010}, url = {https://doi.org/10.1001/jamaneurol.2020.2734} } @article{nasrallah2021-33683313, author = {Nasrallah, I. M. and Gaussoin, S. A. and Pomponio, R. and Dolui, S. and Erus, G. and Wright, C. B. and Launer, L. J. and Detre, J. A. and others}, title = {{Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2021.0178}, pmid = {33683313}, url = {https://doi.org/10.1001/jamaneurol.2021.0178} } @article{jeong2025-40112274, author = {Jeong, S. Y. and Suh, C. H. and Lim, J. S. and Shim, W. H. and Heo, H. and Choi, Y. and Kim, H. S. and Kim, S. J. and others}, title = {{Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-β Immunotherapy: An Updated Meta-Analysis}}, journal = {Neurology}, year = {2025}, doi = {10.1212/wnl.0000000000213483}, pmid = {40112274}, url = {https://doi.org/10.1212/wnl.0000000000213483} } @article{vanetten2026-912127c4, author = {van Etten, E. S. and others}, title = {{Amyloid-Related Imaging Abnormalities (ARIA) in Anti-Amyloid Therapies for Alzheimer's Disease: An Update from the Alzheimer's Association ARIA Workgroup}}, journal = {Alzheimer's \& Dementia}, year = {2026} } @article{salloway2018-30231896, author = {Salloway, S. and Honigberg, L. A. and Cho, W. and Ward, M. and Friesenhahn, M. and Brunstein, F. and Quartino, A. and Clayton, D. and others}, title = {{Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)}}, journal = {Alzheimer's research \& therapy}, year = {2018}, doi = {10.1186/s13195-018-0424-5}, pmid = {30231896}, url = {https://doi.org/10.1186/s13195-018-0424-5} } @article{atri2011-21555634, author = {Atri, A. and O'Brien, J. L. and Sreenivasan, A. and Rastegar, S. and Salisbury, S. and DeLuca, A. N. and O'Keefe, K. M. and LaViolette, P. S. and others}, title = {{Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials}}, journal = {Archives of neurology}, year = {2011}, doi = {10.1001/archneurol.2011.94}, pmid = {21555634}, url = {https://doi.org/10.1001/archneurol.2011.94} } @article{wang2025-40552996, author = {Wang, T. and Yan, S. and Shan, Y. and Xue, H. and Xing, Y. and Bi, S. and Chen, Z. and Xi, H. and others}, title = {{Modulation of Cortical and Hippocampal Functional MRI Connectivity Following Transcranial Alternating Current Stimulation in Mild Alzheimer Disease}}, journal = {Radiology}, year = {2025}, doi = {10.1148/radiol.241463}, pmid = {40552996}, url = {https://doi.org/10.1148/radiol.241463} } @article{rohatgi2025-41038644, author = {Rohatgi, Saurabh and Zhu, Shenghua and Calle, Esteban and Ford, Jeremy N. and Kozak, Benjamin M. and Chagui, Odette Ganem and Vejdani‐Jahromi, Maryam and Griffin, Harry R. and others}, title = {{Are Deep White Matter Hyperintensities Associated with Amyloid-Related Imaging Abnormalities in Patients with Alzheimer Disease Treated with Lecanemab?}}, journal = {American Journal of Neuroradiology}, year = {2025}, doi = {10.3174/ajnr.a8822}, pmid = {41038644}, url = {https://doi.org/10.3174/ajnr.a8822} } @article{okonkwo2025-39760440, author = {Okonkwo, Ozioma C. and Mindt, Mónica Rivera and Weiner, Michael Walter and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Alzheimer's Disease Neuroimaging Initiative: Two decades of pioneering Alzheimer's disease research and future directions}}, journal = {Alzheimer s \& Dementia}, year = {2025}, doi = {10.1002/alz.14186}, pmid = {39760440}, url = {https://doi.org/10.1002/alz.14186} } @article{thibault2026-41830758, author = {Thibault, Emma G. and Montenegro, Grace A Del Carmen and Becker, John Alex and Price, Julie C. and Healy, B.F and Hanseeuw, Bernard Jimmy and Buckley, Rachel F. and Jacobs, Heidi I.L. and others}, title = {{Amyloid spatial extent with florbetapir-PET for early detection of preclinical Alzheimer’s disease}}, journal = {The Journal of Prevention of Alzheimer s Disease}, year = {2026}, doi = {10.1016/j.tjpad.2026.100529}, pmid = {41830758}, url = {https://doi.org/10.1016/j.tjpad.2026.100529} } @article{vanderlip2026-42741980, author = {Vanderlip, Casey R. and Stark, Craig E.L.}, title = {{Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease}}, journal = {Alzheimer s \& Dementia}, year = {2026}, doi = {10.1002/alz.71834}, pmid = {42741980}, url = {https://doi.org/10.1002/alz.71834} } @article{raman2009-19571733, author = {Raman, R. and Thomas, R. G. and Weiner, M. W. and Jack, C. R. and Ernstrom, K. and Aisen, P. S. and Tariot, P. N. and Quinn, J. F.}, title = {{MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population}}, journal = {Alzheimer disease and associated disorders}, year = {2009}, doi = {10.1097/wad.0b013e3181aba588}, pmid = {19571733}, url = {https://doi.org/10.1097/wad.0b013e3181aba588} } @article{ricaurtefajardo2025-39805666, author = {Ricaurte‐Fajardo, Andres and Ivanidze, Jana and Zhang, D. and Mahmud, Meem and Yasen, Weiye and Ravdin, Lisa and Pahlajani, Silky and de Leon, Mony and others}, title = {{Antiamyloid Therapy and Cerebral Blood Flow Changes on MRI: A Potential Longitudinal Biomarker of Treatment Response?}}, journal = {American Journal of Neuroradiology}, year = {2025}, doi = {10.3174/ajnr.a8654}, pmid = {39805666}, url = {https://doi.org/10.3174/ajnr.a8654} } @article{unger2026-42684813, author = {Unger, Robert H. and Rohatgi, Saurabh and Ferraciolli, Suely Fazio and Kako, Bashar and Omid‐Fard, Nima and Imbett, Rafael Eduardo Martinez and Dowling, Thomas and Zhu, Shenghua and others}, title = {{Real-World Challenges in the MRI Detection and Classification of Amyloid-Related Imaging Abnormalities}}, journal = {American Journal of Roentgenology}, year = {2026}, doi = {10.2214/ajr.26.35478}, pmid = {42684813}, url = {https://doi.org/10.2214/ajr.26.35478} } @article{josephmathurin2025-41433752, author = {Joseph‐Mathurin, Nelly and Chen, Charles D. and Hobbs, Diana A. and Jiang, Meng and Flores, Shaney E. and Scott, Jalen and Anand, Sanjana and Franklin, Erin E. and others}, title = {{Imaging‐neuropathology evaluation of Amyloid Related Imaging Abnormality sulcal effusion in a DIAN‐TU‐001 participant treated with gantenerumab}}, journal = {Alzheimer s \& Dementia}, year = {2025}, doi = {10.1002/alz70862_110062}, pmid = {41433752}, url = {https://doi.org/10.1002/alz70862_110062} } @article{josephmathurin2025-41517928, author = {Joseph‐Mathurin, Nelly and Chen, Charles D. and Hobbs, Diana A and Jiang, Meng and Flores, Shaney E. and Scott, Jalen and Anand, Sanjana and Franklin, Erin E. and others}, title = {{Imaging‐neuropathology evaluation of Amyloid Related Imaging Abnormality sulcal effusion in a DIAN‐TU‐001 participant treated with gantenerumab}}, journal = {Alzheimer s \& Dementia}, year = {2025}, doi = {10.1002/alz70856_107139}, pmid = {41517928}, url = {https://doi.org/10.1002/alz70856_107139} } @article{franceschi2025-40639970, author = {Franceschi, Ana Marija and Keir, Graham and Benzinger, Tammie L.S. and Cogswell, Petrice M. and Ali, Farzana Zulfiqar and Petrella, Jeffrey R. and Prescott, Jeffrey W. and Whitlow, Christopher T. and others}, title = {{Clinical Role of Brain PET in Alzheimer Disease in the Era of Disease-Modifying Therapies}}, journal = {American Journal of Neuroradiology}, year = {2025}, doi = {10.3174/ajnr.a8738}, pmid = {40639970}, url = {https://doi.org/10.3174/ajnr.a8738} } @article{petrella2025-40738658, author = {Petrella, Jeffrey R. and Liu, Ao and Wang, Li and Doraiswamy, Pudugramam Murali}, title = {{Artificial Intelligence–Assisted Detection of Amyloid-Related Imaging Abnormalities: Promise and Pitfalls}}, journal = {American Journal of Neuroradiology}, year = {2025}, doi = {10.3174/ajnr.a8946}, pmid = {40738658}, url = {https://doi.org/10.3174/ajnr.a8946} } @article{petrella2026-42747213, author = {Petrella, Jeffrey R. and Barkhof, Frederik and Benzinger, Tammie L.S. and Cogswell, Petrice M. and Franceschi, Ana Marija and Sabbagh, Marwan Noel and Salloway, Stephen and Zaharchuk, Greg and others}, title = {{Artificial Intelligence–Based Detection of ARIA on MRI During Alzheimer Disease Therapy: Expert Opinion on Responsible Clinical Integration}}, journal = {American Journal of Roentgenology}, year = {2026}, doi = {10.2214/ajr.26.35514}, pmid = {42747213}, url = {https://doi.org/10.2214/ajr.26.35514} } @article{ricciardi2025-7cc0ff47, author = {Ricciardi, Mario Emiliano and Burgueño‐García, Iván and Valeriano-Lorenzo, Elizabeth and Zea‐Sevilla, María Ascensión and Valenti, Meritxell and Frades, Belén and Torres, Isabel López and Anton‐Moreno, Marta and others}, title = {{Neuropathological evaluation of the Boston Criteria v2.0 for cerebral amyloid angiopathy in Alzheimer's disease dementia}}, journal = {Alzheimer s \& Dementia}, year = {2025}, doi = {10.1002/alz70856_105538}, url = {https://doi.org/10.1002/alz70856_105538} } @article{anzai2025-40903623, author = {Anzai, Yoshimi and Minoshima, Satoshi}, title = {{The role of brain MR and FDG-PET in the diagnosis of neurodegenerative disease}}, journal = {European Radiology}, year = {2025}, doi = {10.1007/s00330-025-11940-3}, pmid = {40903623}, url = {https://doi.org/10.1007/s00330-025-11940-3} } @article{vandenbroek2025-41381239, author = {van den Broek, Sara Lopes and Bratteby, Klas and Aguilar, Ximena and Tran, Thuy and Syvänen, Stina and Sehlin, Dag}, title = {{Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody}}, journal = {Journal of Nuclear Medicine}, year = {2025}, doi = {10.2967/jnumed.125.271194}, pmid = {41381239}, url = {https://doi.org/10.2967/jnumed.125.271194} } @article{healy2025-41312794, author = {Healy, Madeleine and Thomas, Sarah T and Brodtmann, Amy G.}, title = {{Magnetic resonance imaging eligibility for anti‐amyloid monoclonal antibody treatment for Alzheimer disease: a single‐centre retrospective review for service planning}}, journal = {Internal Medicine Journal}, year = {2025}, doi = {10.1111/imj.70254}, pmid = {41312794}, url = {https://doi.org/10.1111/imj.70254} }